Cure.ai

Experts at City of Hope, a cancer research and treatment center, believe that AI tools will continue to improve precision medicine, streamline patient care and increase access to clinical trials.

India's healthtech startups attracted approximately USD 233.5 million in funding, in the first half of 2024. Yet, behind the numbers lies a pressing question echoing across clinics, policy tables, and investor meetings: Is artificial intelligence (AI) the panacea India's overburdened healthcare system needs,

In recent years, the rapid advancement of artificial intelligence (AI) has ushered in a transformative era in medical and biological research.

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development. Traditional methods often take over a decade and billions of dollars to bring a single drug to market,

To tackle data-retrieval-based hallucinations in non-diagnostic use cases, Mayo Clinic has applied CURE reverse RAG paired with vector databases.

Medical errors are the third leading cause of death in the U.S., contributing to over 250,000 preventable deaths each year. NeuralCure AI is tackling this crisis head-on by eliminating diagnostic blind spots and accelerating treatment precision with its cutting-edge AI-driven decision support system.